CG
TMDX icon

Caprock Group’s Transmedics TMDX Stock Holding History

Caprock Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230K Buy
2,312
+295
+15% +$38.5K 0.01% 1008
2025
Q4 		$245K Buy
+2,017
New +$253K 0.01% 1054

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caprock Group's TMDX Position: Q1 2026 in Review

Caprock Group increased its Transmedics (TMDX) stake by 15% in Q1 2026, buying an estimated $38.5K and bringing the position to 2,312 shares worth $230K. The position accounts for 0.01% of the portfolio, ranked #1008.

Caprock Group first reported a position in TMDX in Q4 2025 and has held it in 2 quarters since. The position peaked at $245K in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Caprock Group held 2,312 shares of Transmedics worth $230K as of Q1 2026.
  • Caprock Group bought 295 Transmedics shares in Q1 2026, an estimated $38.5K.
  • Transmedics made up 0.01% of Caprock Group's portfolio in Q1 2026, its #1008 holding.
  • Caprock Group first reported a position in Transmedics in Q4 2025 and has held it in 2 quarters since.
  • Caprock Group's Transmedics position peaked at $245K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.